Cancer Screening in Lesbian and Bisexual Women and Trans Men

 

Natal women

Transgender men [15]

Cancer type

ACS [51]

USPSTF [3]
 
Bladder

No recommended screening test

No recommended screening test

No recommendation made

Breast

Age 20–39: CBE every 3 years Age ≥ 40: CBE annually Mammogram annually as long as good health

Age 40–49: Individual decision about mammogram based on discussion with clinician Age 50–74: Mammogram every 2 years

Chest wall/axillary exam annually Mammography same as for natal women Mammogram not needed following chest reconstruction

Cervical

Age 21–29: Pap smear ever 3 years Age 30–65: Pap smear plus HPV test every 5 years; or Pap smear every 3 years

Age 21–29: Pap smear ever 3 years Age 30–65: Pap smear plus HPV test every 5 years; or Pap smear every 3 years

Ovaries removed, uterus/cervix intact: Same as natal women; may defer if no history of genital sexual activity; inform pathologist of current or prior testosterone use

Colon-Rectum

Age ≥ 50: Colonoscopy every 10 years; or Flexible sigmoidoscopy every 5 years; or Double-contrast barium enema every 5 years; or CT colonography every 5 year High-sensitivity fecal occult blood test annually

Age ≥ 50: Colonoscopy every 10 years; or Flexible sigmoidoscopy every 5 year with high sensitivity fecal occult blood tests; or High-sensitivity fecal occult blood test annually

No recommendation made

Endometrial (uterine)

No recommended screening test

No recommended screening test

No recommendation made

Lung

Age 55–74 and fairly good health and ≥ 30 pack-year smoking history, and current smoker or quit smoking within last 15 years: Low-dose computed tomography annually

Age 55–80 and asymptomatic and  ≥ 30 pack-year smoking history, and current smoker or quit smoking within last 15 years: Low-dose computed tomography annually; Screening should be discontinued after 15 years of no smoking

Same as for natal women

Oral Cavity

Clinical exam as part of routine dental or physical check-up

No recommended screening tests

No recommendation made

Ovary

No recommended screening test

No recommended screening test

No recommendation made

Skin

Clinical exam as part of routine physical check-up

No recommended screening tests

No recommendation made

Thyroid

Clinical exam as part of routine physical check-up

Recommendations currently being updated

No recommendation made


ACS American Cancer Society, USPSTF United States Preventive Services Task Force, CBE Clinical Breast Exam, FOBT Fecal occult blood test.



To date, there have been no recommendations for cancer screenings specific to lesbian and bisexual women. However, evidence suggests that sexual minority women should be screened based on their age, personal and family risk factors at intervals at least comparable to heterosexual women. Further, some individuals have suggested that cancer screening recommendations for lesbian and bisexual women should be more aggressive than for average-risk women in general because sexual minority women report more risk factors including lower levels of physical activity [4, 5] and diets low in fruits and vegetables [6], as well as higher rates of overweight/obesity [48], smoking [4, 5, 712], alcohol use [46, 9], and nulliparity [6].

Neither the ACS nor USPSTF have published recommendations for screening exams for trans men. However, organizations such as the American College of Obstetrics and Gynecology have provided opinions [13] and/or attempted to use limited available data to provide recommendations for cancer screenings for trans individuals [14, 15]. Table 6.1 (column 4) summarizes the recommendations compiled by the Center for Excellence in Transgender Health at the University of California, San Francisco [15] for trans men. In general, they recommend that screening should be conducted for the anatomy that is present regardless of an individual’s self-description or identity. They also distinguish between those who have used cross-sex hormones or had gender-affirming surgery from those who have not. They recommend that for those who have not used hormones or had surgery the same criteria and risk parameters be used as for persons of their natal sex. Recommendations for those who have used hormones and/or had surgery vary depending on the type of surgery received and current and past hormone use.



Cancer Screening Prevalence


The majority of studies of cancer screening rates among lesbian and bisexual women have focused on screening for breast and/or cervical cancer with screening for colon-rectum cancers only included in more recent studies. To our knowledge, no study has explicitly included lesbian and bisexual individuals in any lung cancer screening studies.

We are also not aware of any studies of cancer screenings that have explicitly included trans men. However, studies have demonstrated that gender minorities often have many barriers to healthcare, including having no insurance [16, 17], being refused medical care [18], and experiencing uninformed, insensitive, biased, and even abusive providers [18, 19]. Therefore, it is hypothesized that screening rates for trans men may be even lower than those for sexual minorities, who have been documented to have more barriers to care than heterosexual individuals.


Breast Cancer

There have been mixed results from studies comparing mammography screening behaviors among sexual minority and heterosexual women. Although two studies have documented higher mammography rates for lesbian compared to heterosexual women [5, 20], the majority of studies have reported that sexual minority women were less likely than heterosexual women to have had a recent mammogram [8, 21, 22] or there were no differences in mammography rates by sexual orientation [2326]. Cross-sectional data from at least three large population- [21, 22] and community-based [8] samples suggest that sexual minority women may be less likely to be screened for breast cancer than heterosexual women. For example, in multi-lingual population-based surveys of more than 18,000 adults in New York City, Kerker et al. [21] found that women who had sex with women (WSW) were less likely to have had a mammogram in the past 2 years (53 vs. 73 %) than other women. Next, using a combined sample of almost 47,000 women from the 2000–2007 Behavioral Risk Factor Surveillance Surveys (BRFSS), Buchmueller and Carpenter [22] found that women in same-sex relationships were significantly less likely to have had recommended mammograms (adjusted odds ratio [AOR] = 0.75; 95 % CI = 0.61, 0.92) than women in different-sex relationships. Finally, Cochran et al. [8] found that 73 % of women aged 40–49 years and 83 % of women aged 50–75 years who described themselves as lesbian or bisexual in a combined sample of nearly 12,000 women from seven U.S. surveys of sexual minority women reported ever receiving a mammogram, compared to 87–90 % of women in U.S. general population surveys [8].

On the other hand, data from two cohort studies [6, 27] and one cross-sectional population-[28] and community-based sample [25] found no differences between lesbian and heterosexual women. For example, Valanis et al. [6] found that among a cohort sample of more than 93,000 women in the Women’s Health Initiative (WHI), rates of having received a mammogram in the past 2 years among those aged 50–79 were comparable for lifetime lesbians (sex only with women ever; 82 %), adult lesbians (sex only with women after age 45 years; 84 %), and heterosexual women (84 %). Similarly, Austin et al. [27] compared prior 2 year mammography rates among 85,756 women in the Nurses’ Health Study (NHS) II aged 40–60 years and found comparable rates for lesbian (82 %) and heterosexual women (84 %). Using a combined sample of more than 52,000 women from 10 states in the 2010 Behavioral Risk Factor Surveillance Surveys (BRFSS), Blosnich et al. [28] found no significant differences in ever having received a mammogram for lesbian (59 %), and heterosexual (65 %) women after controlling for differences in demographic characteristics. Finally, in a cross-sectional, community-based sample of more than 1600 women in Los Angeles, Mays et al. [25] reported that 2-year screening rates for women  ≥ 40 years were comparable for Hispanic (62 %) and African American (88 %) lesbians compared to Hispanic (76 %) and African American (82 %) heterosexual women after accounting for age, education, and income.

Among studies that have explicitly reported screening rates for bisexual women, rates of mammography screening have generally been lower, although not always statistically significant, for bisexual compared to heterosexual women [6, 20, 24, 27, 28]. For example, in the WHI sample, Valanis et al. [6] found that bisexual women aged 50–79 years were slightly less likely to have received a mammogram in the past 2 years than same-aged heterosexuals (82 vs. 84 %). Similarly, Conron et al. [20] also reported slightly lower rates of ever having had a mammogram for bisexual compared to heterosexual women (56 vs. 59 %) in a sample of more than 27,000 women  ≥ 40 years in the 2001–2008 Massachusetts BRFSS. Bisexual women also had slightly lower 2-year mammography rates than heterosexual women (79 vs. 84 %) in the Nurses’ Health Study II reported by Austin et al. [27]. Finally, Blosnich et al. reported lower rates of ever having had a mammogram for bisexual compared to heterosexual (42 vs. 65 %) women in the combined 10-state BRFSS.


Cervical Cancer

Similar to mammography screening, there have been mixed results from studies comparing gynecological screening behaviors among sexual minority and heterosexual women. Several cross-sectional studies using both population-[21, 22, 29, 30] and community-based [5, 8, 25, 31] samples as well as a cohort study [32], have documented lower rates of Pap testing among sexual minority compared to heterosexual women. For instance, Agenor et al. found lower odds of Pap test use in the past 12 months (OR = 0.40, 95 % CI = 0.23, 0.68) among lesbians compared to heterosexual women in the 2006–2010 National Survey of Family Growth [30]. Combining 4 years of population-based data (2001, 2003, 2005, and 2007) from the California Health Interview Survey, Boehmer et al. found that lesbians (65 %) were less likely than heterosexual (74 %) and bisexual (77 %) women to report having had a Pap test in the prior year [29]. Kerkeret al. [21] reported that women who had sex with women (WSW) were less likely to have had a Pap test in the past 3 years (66 vs. 88 %) than other women in the New York City multi-lingual population-based surveys. In the combined BRFSS sample, Buchmueller and Carpenter [22] found that women in same-sex relationships were significantly less likely to have had a Pap test in the past 3 years (adjusted odds ratio [AOR]= 0.74; 95 % CI = 0.57, 0.97) than women in different-sex relationships. Data were similar for some community-based samples. For example, using data from a multisite survey of women 20–86 years, Matthews et al. [31] found that lesbians were less likely to report annual Pap test screening (49 vs. 66 %) and receipt of a Pap test every 3 years (81 vs. 90 %) compared to heterosexual women. Mays et al. [25] also reported that 2-year Pap test rates were lower for Hispanic (70 %) and African American (76 %) lesbians compared to Hispanic (81 %) and African American (81 %) heterosexual women in their Los Angeles sample of racial and ethnic minority women. Finally in the cohort of women who were part of the Growing Up Today Study, Charlton et al. found lower odds of receipt of a Pap test in the past year among lesbian (AOR = 0.25, 95 % CI = 0.12, 0.52) and mostly heterosexual/bisexual women (AOR = 0.70, 95 % CI = 0.54, 0.92) compared to heterosexual women [32].

On the other hand, at least four studies, including cohort [6], population-based [20, 28], and community-based samples [26] have shown no differences in Pap test screening rates by sexual orientation. For instance, in the WHI sample, age adjusted rates of pap test in the prior 3 years were similar for lifetime lesbians (84 %), adult lesbians (87 %), bisexual women (82 %), and heterosexual women (84 %) [6]. Similarly, Conron et al. [20] found no differences in rates of Pap testing in the prior 3 years among lesbian (90 %), bisexual (87 %), and heterosexual women (90 %) in the Massachusetts BRFSS. Blosnnich et al. [28] also reported no differences in ever having had a Pap test among lesbian (92 %), bisexual (80 %), and heterosexual (93 %) women in the combined 10-state BRFSS survey. Finally, using a community sample of women 40–75 years, Clark et al. [26] reported that women who partner with women or both women and men (75 %) were less likely than women who partner with men (84 %) to be on-schedule for Pap testing according to ACS guidelines. However, there were no differences after controlling for demographic characteristics, health behaviors, cancer-related experiences, and participant recruitment source.


Colorectal Cancer

To date, there have been few studies that have reported screening rates for cancer of the colon-rectum by sexual orientation, and these studies have generally found few differences. For example, in the WHI sample reported by Valanis et al. [6], receipt of a hemoccult screening within the prior 5 years among those 50–79 years was comparable for lifetime lesbians (59 %), adult lesbians (60 %), bisexual women (61 %), and heterosexual women (57 %). Similarly, among women 50 years and older in the Nurses’ Health Study, Austin et al. [27] reported no differences in rates of ever having had a colonoscopy or sigmoidoscopy by sexual orientation (lesbians = 42 %; bisexual women = 39 %; heterosexual women = 39 %). In the Massachusetts BRFSS sample  ≥ 50 years, Conron et al. [20] found no significant differences in ever having had a sigmoidoscopy or colonoscopy when they compared lesbian (58 %, AOR = 1.00, 95 % CI = 0.66, 1.51) and bisexual women (74 %, AOR = 2.16, 97 % CI = 0.96, 4.86) to heterosexual women (56 %). Blosnich et al. also found no differences in ever having had a colorectal cancer exam for lesbian (59 %), bisexual (64 %), and heterosexual (66 %) women in the combined BRFSS sample. Similarly, Boehmer et al. found no differences in ever having had a colorectal cancer exam for lesbian (74 %), bisexual (65 %), and heterosexual (68 %) women 50 years of age and older in the California population-based sample. Finally, in a community sample of 600 women, Clark et al. [26] reported that among women 50–75, 65 % of women who partnered with women or with both men and women and 67 % of women who partnered with men were on-schedule for colorectal cancer screening according to the American Cancer Society screening guidelines.


Summary

Despite the number of large-scale cohort, population- and community-based studies, it is not possible to unequivocally conclude whether or not there are differences in the prevalence of cancer screenings by sexual orientation. The strongest evidence presented is for cervical screening where the majority of relevant studies have documented lower rates among sexual minority compared to heterosexual women. There are a number of possible explanations for the mixed results for the other types of cancer screenings. First, studies differed in measures of sexual orientation. Some used identity to classify women but differed as to whether they combined lesbian and bisexual women together or analyzed them separately. Other studies used behavior (e.g., women who have sex with women versus women who have sex with men) to identify sexual minority women. Second, data were collected in different geographic regions. These geographic regions may differ in their screening rates due to density of screening facilities [33] as well as the availability and accessibility of cancer screening programs, particularly for uninsured and underinsured women [34]. Third, studies differed with regard to the age eligibility of women included in the analyses of the respective screening exams. For example, some studies of mammographic screening included all women regardless of age despite the fact that it is not recommended by any professional organization before age 40 years. Fourth, studies differed in the proportion of racial and ethnic minority women included in the sample. For example, some studies were comprised of almost all white women whereas other studies included higher proportions of racial and ethnic minority women consistent with the populations from which the samples were drawn (e.g., New York City, Massachusetts, California). Finally, studies differed in the definition of the screening outcome. For example, intervals for on-schedule Pap testing included the past 12 months, past 2 years and past 3 years. Similarly, colon-cancer screening differed in interval as well as type of test (e.g., lifetime colonoscopy versus past 5-year fecal occult blood test).


Barriers and Facilitators to Cancer Screening



Barriers to Cancer Screening Among LBT Communities


Prior research has suggested that one of the largest barriers to sexual minority women seeking health care in general is fear of disclosing their sexual orientation to providers and the consequences that the disclosure may present. There is considerable data confirming that sexual minority women have had negative experiences with providers due to homophobic attitudes, inappropriate reactions and discrimination [35, 36]. In qualitative studies, sexual minority women report that these types of negative experiences as well as fear of discrimination due to sexual orientation are also barriers to cancer screenings [37, 38]. However, as shown in Table 6.2, there have been few empirical studies that have identified barriers and facilitators associated with breast and/or cervical cancer screenings among sexual minority women. Some of these studies have identified perceived or actual discrimination in health care settings, lack of trust in providers, and lack of provider knowledge about sexual minority health issues as barriers to screening. However, the majority of identified barriers and facilitators in studies of sexual minority women are common to women in general, such as lack of health insurance and/or a regular health care provider, competing life demands, body image, discomfort with the procedure, and fear of the outcome of the exam.



























Barriers and Facilitators

Breast screening

Cervical screening

Barriers
   

Personal Factors
   

Competing life demands such as taking time off from work

Lauver et al. 1999 [38]

Clark et al. 2009 [26]
 

Fear and embarrassment

Lauver et al. 1999 [38]

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 28, 2016 | Posted by in ONCOLOGY | Comments Off on Cancer Screening in Lesbian and Bisexual Women and Trans Men

Full access? Get Clinical Tree

Get Clinical Tree app for offline access